RecruitingNCT05500859

Swiss Secondary Prevention and Rehabilitation Registry

Swiss Secondary Prevention and Rehabilitation Registry: SwissPR


Sponsor

University Hospital, Basel, Switzerland

Enrollment

4,000 participants

Start Date

Dec 20, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The SwissPR study is to continuously monitor patient characteristics and short- and long-term benchmark quality measures and outcomes of patients participating in a 12-week ambulatory CR program.


Eligibility

Inclusion Criteria2

  • Participation in an ambulatory CR program (all age groups)
  • Written informed consent

Exclusion Criteria4

  • Inability to follow an ambulatory CR program more than 3 weeks
  • Not willing to give informed consent
  • Inability to understand the informed consent due to language comprehension
  • Lack of discernment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection at Baseline, 3 months after baseline (BL), 1-year follow-up, Telephone follow-up and questionnaire 3 years and 5 years after BL

Data collection (Patient characteristics including medical history, current medication, cardiovascular risk factors, routine laboratory analysis (including lipids, Hb1c, NT-proBNP), clinical status, electrocardiogram, echocardiography data from latest echo, cardio pulmonary exercise testing (CPET), questions on general health behavior (diet, weekly exercise load), Quality of Life and questions on socio-economic parameters)


Locations(1)

University Hospital Basel, Division of Outpatient Cardiology

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05500859


Related Trials